Changchun GeneScience Pharmaceutical Co., Ltd.

Changchun GeneScience Pharmaceutical Co., Ltd. (GenSci) is a prominent Chinese biopharmaceutical company founded in 1996. It is a subsidiary of the publicly traded Changchun High-Tech Industries (Group) Co., Ltd. GenSci specializes in the research, development, manufacturing, and commercialization of innovative biopharmaceuticals, with a strong focus on pediatric and women's health, endocrinology, oncology, immunology, and respiratory diseases. The company is widely recognized as Asia's largest manufacturing base for recombinant human growth hormone (rhGH) and holds a leading position in the development of long-acting growth hormone therapies. GenSci operates an integrated value chain with R&D centers in Changchun, Shanghai, and Beijing, and maintains a significant commercial presence in China and expanding international operations.